Skip to main content
Top
Published in: BMC Pediatrics 1/2020

Open Access 01-12-2020 | Acute Kidney Injury | Research article

Impact of congenital heart disease on outcomes among pediatric patients hospitalized for influenza infection

Authors: Laxmi V. Ghimire, Fu-Sheng Chou, Anita J. Moon-Grady

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Young children and those with chronic medical conditions are at risk for complications of influenza including cardiopulmonary compromise. Here we aim to examine risks of mortality, clinical complications in children with congenital heart disease (CHD) hospitalized for influenza.

Methods

We analyzed data from in-hospital pediatric patients from 2003, 2006, 2009, 2012 and 2016 using the nationally representative Kids Inpatient Database (KID). We included children 1 year and older and used weighted data to compare the incidence of in-hospital mortality and rates of complications such as respiratory failure, acute kidney injury, need for mechanical ventilation, arrhythmias and myocarditis.

Results

Data from the KID estimated 125,470 children who were admitted with a diagnosis of influenza infection. Out of those, 2174(1.73%) patients had discharge diagnosis of CHD. Children with CHD who required hospitalization for influenza had higher in-hospital mortality (2.0% vs 0.5%), with an adjusted OR (aOR) of 2.8 (95% CI: 1.7–4.5). Additionally, acute respiratory failure and acute kidney failure were more likely among patients with CHD, with aOR of 1.8 (95% CI: 1.5–2.2) and aOR of 2.2 (95% CI: 1.5–3.1), respectively. Similarly, the rate of mechanical ventilatory support was higher in patients with CHD compared to those without, 14.1% vs 5.6%, aOR of 1.9 (95% CI: 1.6–2.3). Median length of hospital stay in children with CHD was longer than those without CHD [4 (IQR: 2–8) days vs. 2 (IQR: 2–4) days]. Outcomes were similar between those with severe vs non-severe CHD.

Conclusions

Children with CHD who require hospital admission for influenza are at significantly increased risk for in-hospital mortality, morbidities, emphasizing the need to reinforce preventative measures (e.g. vaccination, personal hygiene) in this particularly vulnerable population.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.CrossRef Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.CrossRef
3.
go back to reference Homaira N, Briggs N, Oei J-L, Hilder L, Bajuk B, Snelling T, et al. Impact of influenza on hospitalization rates in children with a range of chronic lung diseases. Influenza Other Respir Viruses. 2019;13:233–9.CrossRef Homaira N, Briggs N, Oei J-L, Hilder L, Bajuk B, Snelling T, et al. Impact of influenza on hospitalization rates in children with a range of chronic lung diseases. Influenza Other Respir Viruses. 2019;13:233–9.CrossRef
7.
go back to reference Lumley T. Survey: analysis of complex survey samples. R package version 3.35–1; 2019. Lumley T. Survey: analysis of complex survey samples. R package version 3.35–1; 2019.
9.
go back to reference Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, et al. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev. 2012;17:177–90.CrossRef Colombo PC, Ganda A, Lin J, Onat D, Harxhi A, Iyasere JE, et al. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev. 2012;17:177–90.CrossRef
10.
go back to reference Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol. 2013;167:2397–403.CrossRef Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol. 2013;167:2397–403.CrossRef
11.
go back to reference Fagnoul D, Pasquier P, Bodson L, Ortiz JA, Vincent J-L, De Backer D. Myocardial dysfunction during H1N1 influenza infection. J Crit Care. 2013;28:321–7.CrossRef Fagnoul D, Pasquier P, Bodson L, Ortiz JA, Vincent J-L, De Backer D. Myocardial dysfunction during H1N1 influenza infection. J Crit Care. 2013;28:321–7.CrossRef
12.
go back to reference Lee VJ, Ho ZJM, Goh EH, Campbell H, Cohen C, Cozza V, et al. Advances in measuring influenza burden of disease. Influenza Other Respir Viruses. 2018;12:3–9.CrossRef Lee VJ, Ho ZJM, Goh EH, Campbell H, Cohen C, Cozza V, et al. Advances in measuring influenza burden of disease. Influenza Other Respir Viruses. 2018;12:3–9.CrossRef
13.
14.
go back to reference Kalligeros M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, van Aalst R, Chit A, et al. Influenza vaccine effectiveness against influenza-associated hospitalization in children: a systematic review and meta-analysis. Vaccine. 2020;38:2893–903.CrossRef Kalligeros M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, van Aalst R, Chit A, et al. Influenza vaccine effectiveness against influenza-associated hospitalization in children: a systematic review and meta-analysis. Vaccine. 2020;38:2893–903.CrossRef
16.
go back to reference Livni G, Wainstein A, Birk E, Chodick G, Levy I. Influenza vaccination rate and reasons for nonvaccination in children with cardiac disease. Pediatr Infect Dis J. 2017;36:e268–71.CrossRef Livni G, Wainstein A, Birk E, Chodick G, Levy I. Influenza vaccination rate and reasons for nonvaccination in children with cardiac disease. Pediatr Infect Dis J. 2017;36:e268–71.CrossRef
18.
go back to reference Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5 (CD005050). Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5 (CD005050).
19.
go back to reference Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, et al. Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial. JACC Heart Fail. 2016;4:152–8.CrossRef Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, et al. Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial. JACC Heart Fail. 2016;4:152–8.CrossRef
Metadata
Title
Impact of congenital heart disease on outcomes among pediatric patients hospitalized for influenza infection
Authors
Laxmi V. Ghimire
Fu-Sheng Chou
Anita J. Moon-Grady
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02344-x

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue